Explore: Digital Health · Medtech · Drug Discovery · Generative AI · Seed · Series A · Series B
Bertelsmann Healthcare Investments
Bertelsmann Investments
Bertelsmann Healthcare Investments (BHI) is a healthcare investment firm that sits inside Bertelsmann Investments, the company’s global investment arm with over $2 billion AUM. BHI actively invests across the U.S., Europe, and Israel, supporting founders from day one to early growth and beyond.
Bertelsmann Healthcare Investments (Bertelsmann Investments) invests at seed, Series A and Series B, focuses on Digital Health, Medtech, Drug Discovery and Generative AI, backs founders in United States and Europe.
Stages
Sectors
Geographies
Headquarters
Germany
🔒 Team & partners
Sign in to view🔒 Live funding signals
Sign in to view🔒 Contacts
Sign in to viewSign in to see Bertelsmann Healthcare Investments's full profile
Team & partners, portfolio, live funding signals and contacts. Free account, Google sign-in.
Create free accountVerified 14 July 2026 · Sources: company website, Fusion42 review
Frequently asked questions
- What does Bertelsmann Healthcare Investments invest in?
- Bertelsmann Healthcare Investments invests in Digital Health, Medtech, Drug Discovery and Generative AI at the seed, series-a and series-b stages.
- Which geographies does Bertelsmann Healthcare Investments focus on?
- Bertelsmann Healthcare Investments focuses on United States and Europe, and is headquartered in Germany.